Synthesis and preclinical characterization of [18F]FPBZA: a novel PET probe for melanoma - Wikidata - awgldk - TriplyDB

Synthesis and preclinical characterization of [18F]FPBZA: a novel PET probe for melanoma

Synthesis and preclinical characterization of [18F]FPBZA: a novel PET probe for melanoma

http://www.wikidata.org/entity/Q34194522

about

In Vivo Imaging of Experimental Melanoma Tumors using the Novel Radiotracer 68Ga-NODAGA-Procainamide (PCA).Selective targeting of melanoma using N-(2-diethylaminoethyl) 4-[18F]fluoroethoxy benzamide (4-[18F]FEBZA): a novel PET imaging probe.PET and SPECT imaging of melanoma: the state of the art.

P2860

Q37738077-F374C94F-BBB4-4083-8BAA-9E8D2B8839E2 Q38695346-09CA0521-068C-4BBE-9BD7-C91EB5B1007C Q47868574-0A1B99D7-2472-4423-9AF7-1B39DCE1E624

P2860

Synthesis and preclinical characterization of [18F]FPBZA: a novel PET probe for melanoma

http://www.wikidata.org/entity/Q34194522

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Synthesis and preclinical characterization of [18F]FPBZA: a novel PET probe for melanoma

@ast

Synthesis and preclinical characterization of [18F]FPBZA: a novel PET probe for melanoma

@en

Synthesis and preclinical characterization of [18F]FPBZA: a novel PET probe for melanoma

@nl

type

label

Synthesis and preclinical characterization of [18F]FPBZA: a novel PET probe for melanoma

@ast

Synthesis and preclinical characterization of [18F]FPBZA: a novel PET probe for melanoma

@en

Synthesis and preclinical characterization of [18F]FPBZA: a novel PET probe for melanoma

@nl

prefLabel

Synthesis and preclinical characterization of [18F]FPBZA: a novel PET probe for melanoma

@ast

Synthesis and preclinical characterization of [18F]FPBZA: a novel PET probe for melanoma

@en

Synthesis and preclinical characterization of [18F]FPBZA: a novel PET probe for melanoma

@nl

P1433

Q34194522-06998070-BA86-4E12-87CE-72121938AF5C

P1476

Q34194522-7EA34D40-7E4D-4F6E-8B52-F05C94568DA6

P2093

Q34194522-6E1B78BC-C3B6-4E46-B8FD-D0856FDD8E48

Q34194522-78F3FEFB-B18C-484D-96C7-43514C485580

Q34194522-B042E499-D4BA-471F-8302-F49A0F7BFE81

Q34194522-B720C360-E7DC-4AA4-9397-3DF5A646C2EC

P2860

Q34194522-05B11E94-611D-4F3D-A6A2-9414C05A9F18

Q34194522-0BA85AAA-ED3C-4EA3-8F71-527967228AB3

Q34194522-1887FB60-CBCF-4891-B126-8BB3753787B5

Q34194522-2E26912E-62EE-44C5-8676-10FCEE587447

Q34194522-2E4148F8-0C0B-4F7D-8DED-5CA86710128A

Q34194522-3708E2FA-FE3C-47A8-91A9-9F14891FC54A

Q34194522-4D9F2C1C-79F7-4527-8A2F-C4B750771F29

Q34194522-5D648DFB-7A32-4657-B4F1-0EB387985A2E

Q34194522-60D5AF84-36D8-4938-9991-20C2F6180B08

Q34194522-63852C59-2830-462B-8FC1-CA3367408301

P304

Q34194522-517C4736-0335-43BB-9EC2-7554441A78A6

P31

Q34194522-89CE890F-E7E6-4AA2-AB93-83BE4FC72C5D

P356

Q34194522-43EC73B2-7482-4618-900B-3B1896650335

P407

Q34194522-A0205AE8-099D-44D3-9242-8616BF5D0F73

P478

Q34194522-72D83948-1A9B-4A33-AE67-907855C4F39D

P50

Q34194522-4A61352E-679A-4750-9C88-0A498A4103C7

Q34194522-67510453-5E80-4419-907C-594A8422282B

Q34194522-EF3EA097-ABA1-4829-B187-BCD354A17FFA

Q34194522-F69B9BDB-A7C7-464A-96BA-596F9158EA38

P577

Q34194522-D16B487E-CAB0-4315-A339-A86110F92A61

P5875

Q34194522-15716E96-0756-421A-842E-63C569D791C9

P698

Q34194522-E306A990-3614-404B-991E-65B87939C36D

P932

Q34194522-8DBB511A-73E4-437D-892F-CECFE7E29087

P356

P1433

BioMed Research International

P1476

Synthesis and preclinical characterization of [18F]FPBZA: a novel PET probe for melanoma

@en

P2093

Chih-Chieh Shen

http://www.w3.org/2001/XMLSchema#string

Ren-Shyan Liu

http://www.w3.org/2001/XMLSchema#string

Shih-Pin Huang

http://www.w3.org/2001/XMLSchema#string

Yen-Chen Lo

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2013

Clinical use of positron emission tomography in the management of cutaneous melanoma.

PET of malignant melanoma using 18F-labeled metallopeptides.

Melanin-targeted preclinical PET imaging of melanoma metastasis.

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma.

Radiofluorinated rhenium cyclized α-MSH analogues for PET imaging of melanocortin receptor 1.

Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma.

An evidence-based staging system for cutaneous melanoma.

Management of cutaneous melanoma.

Role of nuclear medicine in the management of cutaneous malignant melanoma.

P304

912498

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/912498

http://www.w3.org/2001/XMLSchema#string

P407

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266151177

http://www.w3.org/2001/XMLSchema#string

P698

25254219

http://www.w3.org/2001/XMLSchema#string

P932

4165567

http://www.w3.org/2001/XMLSchema#string